Chronic pain affects millions of people in the US. Targeting an oft-overlooked brain receptor could one day offer relief.

A painkiller developed by Germany's Algiax Pharma has shown efficacy in the treatment of chronic neuropathic pain, another positive development in the search for alternatives to opioids. The phase ...

In her new book, “Mind Your Body: A Revolutionary Program to Release Chronic Pain and Anxiety,” the author, podcaster and public speaker shares her method for eliminating not just chronic pain ...

Researchers have developed a wireless implant for chronic pain relief. The ultrasound-powered device adapts to individual ...

MIRA is advancing complementary non-opioid therapies for two of the largest pain markets MIAMI, FLORIDA / ACCESS Newswire / ...

Researchers are developing promising suppression systems for painful conditions—even an app on your phone that turns the pain ...

Explore how AI-powered wireless implants could replace opioids, using ultrasonic energy to block chronic pain signals without addiction risk.

Americans live with chronic pain. A new device created by USC biomedical engineers could help sufferers avoid the need for opioids ...

This groundbreaking device, detailed in Nature Electronics, represents a significant leap forward in pain therapy. While current spinal cord stimulators can be unwieldy and are hard-wired to batteries ...

The Global Neuropathic Pain Market is valued approximately at USD 8.14 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.73% over the forecast period 2024-2032.

Shares of Artelo Biosciences, Inc. (ARTL) more than doubled on Monday after the company announced favorable results from its ...